United States v. Ereme
Opinion
UNPUBLISHED
UNITED STATES COURT OF APPEALS FOR THE FOURTH CIRCUIT
No. 05-4263
UNITED STATES OF AMERICA, Plaintiff - Appellee,
versus
EMMANUEL THAD EREME, Defendant - Appellant.
No. 05-4327
UNITED STATES OF AMERICA, Plaintiff - Appellee,
versus
EMMANUEL THAD EREME, Defendant - Appellant.
No. 06-4575
UNITED STATES OF AMERICA, Plaintiff - Appellee,
versus
EMMANUEL THAD EREME, Defendant - Appellant.
Appeals from the United States District Court for the District of Maryland, at Greenbelt. Peter J. Messitte, District Judge. (CR- 02-478-PJM; 8:02-cr-00478-PJM-2)
Submitted: February 9, 2007 Decided: April 9, 2007
Before WILLIAMS, MOTZ, and SHEDD, Circuit Judges.
Nos. 05-4263, 06-4575 affirmed; No. 05-4327 dismissed by unpublished per curiam opinion.
Steven Gene Berry, Rockville, Maryland, for Appellant. Rod J. Rosenstein, United States Attorney, Deborah Johnston, Bryan E. Foreman, Sandra Wilkinson, Assistant United States Attorneys, OFFICE OF THE UNITED STATES ATTORNEY, Greenbelt, Maryland, for Appellee.
Unpublished opinions are not binding precedent in this circuit.
PER CURIAM:
Emmanuel Thad Ereme appeals his convictions for conspiracy to dispense, distribute, and possess with intent to distribute and unlawful dispensation of Schedule II controlled substances (No. 05- 4263). In addition, Ereme appeals the denial of his motion for a new trial (No. 06-4575). Finding no error, we affirm.1
I
Beginning in 1997, Ereme, a licensed pharmacist, owned and operated Hremt Pharmacy (“Hremt”) in District Heights, Maryland.2 Although Ereme initially served as the sole pharmacist at Hremt, he gradually added other pharmacists to his staff. In addition, Ereme employed pharmacy technicians who assisted with the filling of prescriptions.
In September 1999, the Maryland Drug Control Office, responding to an anonymous tip regarding Hremt’s practices, conducted an audit on generic and brand Percocet. The audit uncovered several irregularities, including facsimile and
1 Ereme also appeals an order of forfeiture entered by the district court (No. 05-4327). By not raising the validity of the forfeiture order in his opening brief, Ereme has waived further consideration of this appeal. Edwards v. City of Goldsboro, 178 F.3d 231, 241 n.6 (4th Cir. 1999). Therefore, we dismiss the appeal in No. 05-4327.
2 We recite the facts in the light most favorable to the Government. See United States v. Murphy, 35 F.3d 143, 144 (4th Cir. 1994).
photocopied prescriptions, large quantities of Schedule II drugs being dispensed, and the filling of controlled substance prescriptions whose refill interval was too soon. The case was referred to the Drug Enforcement Administration (“DEA”), which subsequently received confirmation as to the irregularities discovered earlier. The DEA investigation led to a search of Hremt’s premises on November 2, 2000. This search and further audits indicated that prescriptions written for Joseph Scirigione and prescriptions written by Dr. Beverly Wheatley were suspect.
Between May 8, 1997, and December 31, 2001, Joseph Scirigione and his common law wife, Theresa Gant, obtained 26,400 tablets of Hydromorphone (Dilaudid) and 32,850 tablets of Dolophine (Methadone) from Hremt. These drugs were obtained through 310 prescriptions, 298 of which were for Scirigione and were presented by him. These prescriptions were written on photocopied forms with the letterhead of various medical practices. However, 300 of the prescriptions bore the signature and DEA number of Dr. Robert Hunt and ten bore the signature of Dr. Michelle Craig. Later testimony by Dr. Hunt indicated that his signature was forged on the prescriptions, that a physician would not have issued the number of prescriptions which Scirigione presented, and that the dosages of medication in Scirigione’s prescriptions would have proved fatal for any patient.
Dr. Beverly Wheatley was a licensed dentist who practiced from 1977 to 2001 in the District of Columbia and Maryland. Based on the evidence disclosed in the 2001 search of Hremt, DEA investigators searched Wheatley’s office in April, 2002. There they discovered many irregularities, including a sign advertising the sale of prescriptions for $25 each. Wheatley was arrested and pled guilty to conspiracy to distribute and possess with intent to distribute Schedule II substances. Wheatley testified that she abused prescription medications herself and that she sold prescriptions to patients and directed them to Hremt. Significantly, Wheatley also testified that she signed the prescriptions she issued using various names, including her maiden name, her daughter’s name, and her husband’s name.
On July 21, 2004, Ereme was indicted under a third superseding indictment for conspiracy to dispense, distribute, and possess with intent to distribute Schedule II controlled substances, including Oxycodone (Percocet or Roxicet), Hydromorphone (Dilaudid), and Dolophine (Methadone). The case was tried to a jury, which found Ereme guilty as to all counts. Ereme now appeals, raising several arguments for our consideration.
II
A.
Ereme first contends that the district court improperly limited his testimony on direct examination and thereby infringed his constitutional right to present a defense. Ereme bases this contention on the district court’s denial of his request for additional time in which to complete his defense after he had exhausted the seven days granted by the district court. We review this claim under an abuse of discretion standard, and we will not disturb the district court’s decision unless it acted arbitrarily or irrationally. United States v. Moore, 27 F.3d 969, 974 (4th Cir. 1994).
While a defendant has a constitutional right to testify as part of his own defense, Rock v. Arkansas, 483 U.S. 44, 51-52 (1987), this right is subject to reasonable restrictions, United States v. Scheffer, 523 U.S. 303, 308 (1998). Specifically, a district court, in its discretion, may exercise reasonable control over the interrogation of witnesses and the presentation of evidence in order to avoid needless waste of time. Fed. R. Evid. 611(a). A district court’s actions in this regard do not abridge a defendant’s right to present a defense unless they are arbitrary or disproportionate to the purposes they are designed to serve. Scheffer, 523 U.S. at 308.
The district court granted Ereme’s original request for seven days in which to present his defense. At the completion of this time, the district court permitted Ereme to continue his defense on the morning of the eighth day but refused any additional time. This restriction was reasonable and does not constitute an abuse of discretion. Ereme was aware of the district court’s structure of the trial schedule and of the time allotted to each of the parties. While Ereme did not testify as to the details of each of the more than 800 transactions involved, he did testify about his customers in general and about the Scirigione and Wheatley cases in particular. As the district court noted, Ereme effectively answered the charges against him and contested each of the elements of those charges. Further, he answered the allegations made by his employees regarding his knowledge of the illegal prescriptions and his role in any conspiracy. Ereme has failed to show what additional evidence would have been introduced through his continued testimony, other than further denials of the individual transactions involved. In these circumstances, the district court did not abuse its discretion by placing reasonable time constraints on Ereme’s testimony.
B.
Free access — add to your briefcase to read the full text and ask questions with AI
United States v. Ereme (United States v. Ereme) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.